Advertisement
New Zealand markets closed

  • NZX 50

    11,367.51
    +37.31 (+0.33%)
     

  • NZD/USD

    0.6211
    +0.0054 (+0.88%)
     

  • NZD/EUR

    0.5700
    +0.0052 (+0.92%)
     

  • ALL ORDS

    7,285.10
    -12.60 (-0.17%)
     

  • ASX 200

    7,073.20
    -14.10 (-0.20%)
     

  • OIL

    74.38
    -1.58 (-2.08%)
     

  • GOLD

    2,091.70
    +34.50 (+1.68%)
     

  • NASDAQ

    15,997.58
    +49.71 (+0.31%)
     

  • FTSE

    7,529.35
    +75.60 (+1.01%)
     

  • Dow Jones

    36,245.50
    +294.61 (+0.82%)
     

  • DAX

    16,397.52
    +182.09 (+1.12%)
     

  • Hang Seng

    16,830.30
    -212.58 (-1.25%)
     

  • NIKKEI 225

    33,431.51
    -55.38 (-0.17%)
     

  • NZD/JPY

    91.1520
    -0.0140 (-0.02%)
     

Bio-Rad to Participate in Fireside Chat During Wells Fargo’s 2023 Healthcare Conference

Business Wire
·1-min read

HERCULES, Calif., August 28, 2023--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, today announced that the company’s management will participate in a fireside chat event during Wells Fargo’s 2023 Healthcare Conference on Thursday, September 7 at 11:00 AM Eastern Time (8:00 AM Pacific Time).

A live webcast and subsequent replay of the event will be available in the Investor Relations section of Bio-Rad’s website at bio-rad.com.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with over 8,200 employees and $2.8 billion in revenues in 2022. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230828364522/en/

Contacts

Investor Contact:
Edward Chung, Investor Relations
510-741-6104
ir@bio-rad.com

Media Contact:
Anna Gralinska, Corporate Communications
510-741-6643
cc@bio-rad.com